Related Experiment Video
Updated: Jan 9, 2026
13:35
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
4.0K
Assisted Breast Reconstruction With Biosynthetic Mesh and Implants: A Pilot Study.
Francisco Pimentel Cavalcante1,2,3, Felipe Pereira Zerwes3,4, Eduardo Camargo Millen3,5
1From the Department of Breast Surgery, Fortaleza General Hospital, Fortaleza, Ceará, Brazil.
Plastic and Reconstructive Surgery. Global Open
|December 5, 2025
Summary
GORE BIO-A biosynthetic mesh shows promise for high-risk breast reconstruction patients, offering acceptable complication rates and good quality of life. This study evaluated its use in immediate implant-based breast reconstruction.
Area of Science:
- Plastic Surgery
- Reconstructive Surgery
- Biomaterials
Background:
- Acellular dermal matrices (ADMs) in implant-based breast reconstruction are linked to high complication rates.
- A biosynthetic mesh, GORE BIO-A, may offer a solution by potentially reducing complications while maintaining functional outcomes.
- Previous research has not exclusively evaluated GORE BIO-A in this context.
Purpose of the Study:
- To evaluate the safety and efficacy of GORE BIO-A biosynthetic mesh in immediate implant-based breast reconstruction for high-risk patients.
- To assess complication rates, aesthetic outcomes, and quality of life in this specific patient cohort.
Main Methods:
- Retrospective analysis of 13 patients (23 breasts) undergoing immediate implant-based breast reconstruction with GORE BIO-A.
- Data collection included patient demographics, follow-up duration, implant volume, complication rates (Baker classification), aesthetic outcomes (Harvard scale, BCCT.core), and quality of life (EORTC QLQ-BREC23).
- Statistical analysis was performed to identify factors affecting outcomes, such as radiotherapy.
Main Results:
- Early complications occurred in 6 breasts, all managed conservatively.
- Capsular contracture (Baker grade I) was observed in 18 breasts; radiotherapy was significantly associated with contracture (P=0.03), with 4 of 10 breasts receiving radiotherapy developing grade III contracture.
- Aesthetic outcomes were rated good or excellent in 11/13 (Harvard scale) and 12/13 (BCCT.core) cases. Quality of life scores indicated high satisfaction with surgery (100%), breast (77.8%), and nipple preservation (100%).
Conclusions:
- GORE BIO-A biosynthetic matrix appears feasible for immediate implant-based breast reconstruction in high-risk patients.
- The material demonstrated acceptable complication rates and positive quality-of-life outcomes in this cohort.
- Further research is warranted, but initial findings suggest GORE BIO-A is a viable option for this patient population.
